Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
KLA
KLAC
|
+$355M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$304M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$267M |
| 4 |
Gilead Sciences
GILD
|
+$239M |
| 5 |
Visa
V
|
+$229M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$388M |
| 2 |
Wells Fargo
WFC
|
+$370M |
| 3 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$295M |
| 4 |
Alibaba
BABA
|
+$234M |
| 5 |
IBM
IBM
|
+$210M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.55% |
| 2 | Healthcare | 5.29% |
| 3 | Financials | 4.23% |
| 4 | Communication Services | 3.53% |
| 5 | Energy | 2.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FPO
3376
DELISTED
First Potomac Realty Trust
FPO
| $340K | ﹤0.01% |
37,790
+20
| +0.1% | +$184 |
|
3377
CALL
Neurocrine Biosciences
NBIX
$15.3B
| $339K | ﹤0.01% |
8,700
-40,400
| -82% | -$1.6M |
|
3378
PUT
AGCO
AGCO
$6.96B
| $338K | ﹤0.01% |
6,900
+3,300
| +92% | +$159K |
|
3379
Generac Holdings
GNRC
$12.8B
| $338K | ﹤0.01% |
9,138
-16,734
| -65% | -$539K |
|
3380
LifeVantage
LFVN
$81.9M
| $338K | ﹤0.01% |
37,500
+18,100
| +93% | +$161K |
|
3381
PUT
Radware
RDWR
$1.25B
| $338K | ﹤0.01% |
30,700
+5,500
| +22% | +$66.4K |
|
3382
Veeva Systems
VEEV
$41B
| $338K | ﹤0.01% |
13,527
-13,197
| -49% | -$323K |
|
|
GIG
3383
DELISTED
GigPeak, Inc.
GIG
| $338K | ﹤0.01% |
168,600
+151,100
| +863% | +$405K |
|
3384
CALL
Buckle
BKE
$2.31B
| $337K | ﹤0.01% |
+10,200
| New | +$310K |
|
3385
CALL
Direxion Daily MSCI Emerging Markets Bear 3X ETF
EDZ
$18.5M
| $337K | ﹤0.01% |
198
+8
| +4% | +$20.2K |
|
3386
PUT
State Street SPDR S&P Bank ETF
KBE
$1.75B
| $336K | ﹤0.01% |
+11,200
| New | +$332K |
|
3387
MGP Ingredients
MGPI
$389M
| $336K | ﹤0.01% |
+13,990
| New | +$321K |
|
|
SVU
3388
DELISTED
SUPERVALU Inc.
SVU
| $336K | ﹤0.01% |
9,563
-57,711
| -86% | -$2.05M |
|
|
PAY
3389
PUT
DELISTED
Verifone Systems Inc
PAY
| $336K | ﹤0.01% |
12,000
-7,400
| -38% | -$183K |
|
|
ACAS
3390
PUT
DELISTED
American Capital Ltd
ACAS
| $336K | ﹤0.01% |
22,400
+1,500
| +7% | +$20.9K |
|
3391
Boyd Gaming
BYD
$6.05B
| $335K | ﹤0.01% |
16,773
-189,975
| -92% | -$3.36M |
|
3392
CALL
Interactive Brokers
IBKR
$41.4B
| $335K | ﹤0.01% |
34,400
-62,800
| -65% | -$554K |
|
3393
Supernus Pharmaceuticals
SUPN
$2.74B
| $335K | ﹤0.01% |
22,349
-10,070
| -31% | -$131K |
|
|
RPAI
3394
DELISTED
RETAIL PROPERTIES OF AMERICA, INC.
RPAI
| $335K | ﹤0.01% |
22,298
-4,738
| -18% | -$71.4K |
|
3395
Atlassian
TEAM
$42.1B
| $334K | ﹤0.01% |
13,345
+5,345
| +67% | +$125K |
|
3396
PUT
PPG Industries
PPG
$25.5B
| $333K | ﹤0.01% |
3,000
+700
| +30% | +$68.8K |
|
|
SBY
3397
DELISTED
Silver Bay Realty Trust Corp.
SBY
| $333K | ﹤0.01% |
23,823
+292
| +1% | +$4.11K |
|
3398
CALL
Vertex Pharmaceuticals
VRTX
$131B
| $332K | ﹤0.01% |
4,200
-32,700
| -89% | -$2.96M |
|
3399
CALL
Meritage Homes
MTH
$4.8B
| $331K | ﹤0.01% |
18,400
+4,000
| +28% | +$63.7K |
|
|
WCG
3400
CALL
DELISTED
Wellcare Health Plans, Inc.
WCG
| $331K | ﹤0.01% |
3,600
-23,600
| -87% | -$1.96M |
|
Similar funds
Barclays's Q1 2016 Portfolio in Review
As of Q1 2016, Barclays held 6,944 positions worth $65.6B, down 20% from $82.3B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Barclays withdrew a net $15.2B in Q1 2016, closing 588 positions and reducing 2,924 holdings. Its most notable exit was PRECISION CASTPARTS CORP, an estimated $295M position sold in full.
By sector, the portfolio is most concentrated in Technology at 5.5% of assets, up from 4.9% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Barclays opened a new position in State Street SPDR S&P Pharmaceuticals ETF worth $26M.
- Barclays's largest Q1 2016 buy was State Street SPDR S&P Pharmaceuticals ETF: 650,000 shares worth $26M.
- Barclays added most to KLA in Q1 2016, an estimated $355M increase.
- Barclays's biggest Q1 2016 reduction was Apple, cutting an estimated $388M.
- Barclays fully exited PRECISION CASTPARTS CORP in Q1 2016, selling an estimated $295M.
- Barclays's ten largest holdings make up 29% of its $65.6B portfolio in Q1 2016.
- Barclays opened 766 new positions and closed 588 in Q1 2016.
- Barclays's portfolio value fell 20% quarter-over-quarter to $65.6B.
Based on Barclays's 13F filing for Q1 2016, filed 16 May 2016.